Nanopharmaceutics : (Record no. 765791)

MARC details
000 -LEADER
fixed length control field 06044cam a2200721Ia 4500
001 - CONTROL NUMBER
control field ocn821115168
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20241010144137.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr mn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 121213s2013 si a ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency HKP
Language of cataloging eng
Description conventions pn
Transcribing agency HKP
Modifying agency OCLCO
-- CDX
-- YDXCP
-- N$T
-- OHS
-- IDEBK
-- E7B
-- OCLCF
-- DEBSZ
-- OCLCQ
-- OCLCO
-- OCLCQ
-- D6H
-- AGLDB
-- VGM
-- OCLCQ
-- UAB
-- OCLCQ
-- VTS
-- TOF
-- AU@
-- JBG
-- WYU
-- YOU
-- REC
-- STF
-- UKAHL
-- OL$
-- OCLCO
-- OCLCQ
-- K6U
-- LEAUB
-- OCLCA
-- OCLCO
019 ## -
-- 902865034
-- 1086433884
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789814368674
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9814368679
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9789814368667
Qualifying information (print)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9814368660
035 ## - SYSTEM CONTROL NUMBER
System control number 516998
-- (N$T)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)821115168
Canceled/invalid control number (OCoLC)902865034
-- (OCoLC)1086433884
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number R857.N34
Item number N36 2013eb
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 778
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 023000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 058170
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 072000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1/9
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Nanopharmaceutics :
Remainder of title the potential application of nanomaterials /
Statement of responsibility, etc. editor, Xing-Jie Liang.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. Singapore :
Name of publisher, distributor, etc. World Scientific Pub. Co.,
Date of publication, distribution, etc. ©2013.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (ix, 594 pages) :
Other physical details illustrations (some color)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
520 ## - SUMMARY, ETC.
Summary, etc. Nanomaterials, with their unique size-dependent physical and chemical properties, have shown promising advantages as drug and gene delivery vehicles, ultra-sensitive intracellular detectors and novel therapeutic drugs. Nanopharmaceutics is one of the disciplines that will benefit the most from this technology. Nanotechnology will have a revolutionary impact on cancer diagnosis and therapy due to the exceptional characteristics of nanopharmaceutics. This book provides an overview of some tools, methods, and materials of nanotechnology that offer potential applications in pharmaceutics, followed by a series of examples showing applications that are already in development. It may very well inspire researchers to develop a new generation of pharmaceutics with inventive non-traditional approach and employ nanoscale science for the benefit of the patient.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Ch. 1. Innovative treatments for cancer: the impact of delivering siRNAs, chemotherapies, and preventative agents using nanoformulations / Sara S. Hook [and others] -- ch. 2. Nano-emulsions: overview and applications / Xiang Li, Nicolas Anton and Thierry Vandamme -- ch. 3. Protein nanopharmaceuticals -- Concepts and safety considerations / Eva Horn Moller, Lene Jorgensen and Natalie J. Medlicott -- ch. 4. Nanoscaled proteomic analysis / Yan Xu and Lee Jia -- ch. 5. Tumor targeting potential of Lipid-Based Nano-Pharmaceuticals (LNPs) / Kshitij Gupta [and others] -- ch. 6. Novel methods of lipidic nanoparticle preparation and drug loading / Yoshie M. -- ch. 7. Biomedical properties study of modified chitosan nanoparticles for drug delivery systems / Mohammad Reza Saboktakin -- ch. 8. Dendrimers as nanovectors for nucleic acid delivery / Xiaoxuan Liu, Qi Wang, Ling Peng -- ch. 9. Drug delivery systems for platinum drugs / Vien T. Huynh, Wei Scarano, Martina H. Stenzel -- ch. 10. Improving platinum efficiency: nanoformulations / Rolando Carmona and Xing-Jie Liang -- ch. 11. Design principles of nanoparticles as contrast agents for magnetic resonance imaging / Liang Shan, Xinbin Gu, Paul Wang -- ch. 12. Perfluorocarbon nanoparticles: a theranostic platform technology / G.M. Lanza [and others] -- ch. 13. Potential toxic effects of nano-oxides / Mingsheng Xu [and others] -- ch. 14. Electron spin resonance spectroscopy for studying the generation and scavenging of reactive oxygen species by nanomaterials / Jun-Jie Yin [and others] -- ch. 15. Nanotechnology: a new approach to improve orthopedic implants / Hongjian Zhou, Fangfang Sun, Jaebeom Lee -- ch. 16. In situ controlled release of dopamine for treatment of Parkinson's Disease -- ch. 17. Novel nanotechnology strategies for the treatment and prevention of HIV infection / Jian Jun Tan [and others] -- ch. 18. Interaction of nanoparticles with the immune system and their significance in drug-design and development / Anil Kumar, Bhargavi M. Boruah and Xing-Jie Liang -- ch. 19. Nano-carbon-based systems for the delivery of bioactive agents: pros and cons / Tapas R. Nayak and Giorgia Pastorin -- ch. 20. Nanostructures with biocompatible and biodegradable characteristics / Jie Meng.
590 ## - LOCAL NOTE (RLIN)
Local note WorldCat record variable field(s) change: 650
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Nanomedicine.
9 (RLIN) 86424
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Nanoparticles.
9 (RLIN) 6289
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Nanotechnology.
9 (RLIN) 6108
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Nanomedicine
9 (RLIN) 86424
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Nanoparticles
9 (RLIN) 6289
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Nanoparticules.
9 (RLIN) 106862
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Nanomédecine.
9 (RLIN) 504191
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Drug Guides.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Nursing
-- Pharmacology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
9 (RLIN) 80262
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacy.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Nanomedicine.
Source of heading or term fast
Authority record control number (OCoLC)fst01744350
9 (RLIN) 86424
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Nanoparticles.
Source of heading or term fast
Authority record control number (OCoLC)fst01032624
9 (RLIN) 6289
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
9 (RLIN) 396
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
9 (RLIN) 396
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Liang, Xing-Jie.
9 (RLIN) 663908
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Nanopharmaceutics : the the potential application of nanomaterials.
Place, publisher, and date of publication Singapore : World Scientific Pub. Co., ©2013
International Standard Book Number 9789814368667
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified EBSCOhost
Uniform Resource Identifier <a href="https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=516998">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=516998</a>
938 ## -
-- Askews and Holts Library Services
-- ASKH
-- AH24926162
938 ## -
-- Coutts Information Services
-- COUT
-- 24464883
938 ## -
-- ebrary
-- EBRY
-- ebr10640618
938 ## -
-- EBSCOhost
-- EBSC
-- 516998
938 ## -
-- ProQuest MyiLibrary Digital eBook Collection
-- IDEB
-- cis24464883
938 ## -
-- YBP Library Services
-- YANK
-- 9961400
994 ## -
-- 92
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
  Not Lost     EBSCO Technology e-Library e-Library 10/10/2024   10/10/2024 10/10/2024 eBook

Powered by Koha